Robert Memmott Acquires 40 Shares of Caledonia Investments (LON:CLDN) Stock

Caledonia Investments Plc (LON:CLDN) insider Robert Memmott bought 40 shares of the stock in a transaction that occurred on Tuesday, January 27th. The stock was acquired at an average cost of GBX 374 per share, for a total transaction of £149.60.

Robert Memmott also recently made the following trade(s):

• On Monday, December 15th, Robert Memmott bought 39 shares of Caledonia Investments stock. The shares were bought at an average price of GBX 386 per share, with a total value of £150.54.
• On Thursday, November 27th, Robert Memmott acquired 39 shares of Caledonia Investments stock. The shares were bought at an average price of GBX 382 per share, with a total value of £148.98.

Caledonia Investments Stock Up 0.5%

Shares of Caledonia Investments stock opened at GBX 373 on Friday. Caledonia Investments Plc has a 12-month low of GBX 321.50 and a 12-month high of GBX 395. The stock has a market capitalization of £1.94 billion, a P/E ratio of 10.80 and a beta of 0.77. The company has a 50-day simple moving average of GBX 379.73 and a 200 day simple moving average of GBX 556.36.

Caledonia Investments (LON:CLDN) last released its quarterly earnings results on Tuesday, November 25th. The company reported GBX 7.30 earnings per share for the quarter. Caledonia Investments had a return on equity of 6.98% and a net margin of 86.28%.

About Caledonia Investments

Caledonia is a FTSE 250 self-managed investment trust company with a long track record of delivering consistent returns and progressive annual dividend payments to shareholders.

Our aim is to generate long-term compounding real returns that outperform inflation by 3%-6% over the medium to long term, and the FTSE All-Share index over 10 years.

We are a long-term investor and hold investments in both listed and private markets across three pools: Public Companies, Private Capital and Funds. Each has a strategic allocation of capital, investment strategy and target return.

We buy to hold, investing in high quality companies with strong market positions and fundamentals, alongside investments in private equity funds with track records of success.